Goldfinch Bio's Series A Round

Goldfinch Bio raised a round of funding on December 14, 2016. Investors include Third Rock Ventures.

Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney disease. Recent breakthroughs in genetics and biology have generated an unparalleled understa…

Articles about Goldfinch Bio's Series A Round: